Jacobson, C. A., Farooq, U., & Ghobadi, A. (2019). Axicabtagene Ciloleucel, an Anti‐CD19 Chimeric Antigen Receptor T‐Cell Therapy for Relapsed or Refractory Large B‐Cell Lymphoma: Practical Implications for the Community Oncologist. Oncologist.
استشهاد بنمط شيكاغوJacobson, Caron A., Umar Farooq, و Armin Ghobadi. "Axicabtagene Ciloleucel, an Anti‐CD19 Chimeric Antigen Receptor T‐Cell Therapy for Relapsed or Refractory Large B‐Cell Lymphoma: Practical Implications for the Community Oncologist." Oncologist 2019.
MLA استشهادJacobson, Caron A., Umar Farooq, و Armin Ghobadi. "Axicabtagene Ciloleucel, an Anti‐CD19 Chimeric Antigen Receptor T‐Cell Therapy for Relapsed or Refractory Large B‐Cell Lymphoma: Practical Implications for the Community Oncologist." Oncologist 2019.